Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix
Phase 2
Terminated
- Conditions
- Cervical CancerUterine Cancer
- Interventions
- First Posted Date
- 2008-02-29
- Last Posted Date
- 2014-07-07
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 4
- Registration Number
- NCT00626561
- Locations
- 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
Interactive Voice Response System in Advanced Cancer Patients
Not Applicable
Completed
- Conditions
- Advanced Cancer
- Interventions
- Other: Standard CareBehavioral: Interactive Voice Response System
- First Posted Date
- 2008-02-28
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 136
- Registration Number
- NCT00625638
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Multimodal Treatment Strategy for Cancer Cachexia
Not Applicable
Terminated
- Conditions
- CachexiaAdvanced Cancer
- Interventions
- Behavioral: Graded Resistance TrainingBehavioral: Aerobic ExerciseDrug: MelatoninDietary Supplement: JuvenDrug: AtenololDrug: Ibuprofen
- First Posted Date
- 2008-02-28
- Last Posted Date
- 2016-02-12
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 15
- Registration Number
- NCT00625742
- Locations
- 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia
Phase 2
Terminated
- Conditions
- Hypocalcemia
- Interventions
- First Posted Date
- 2008-02-26
- Last Posted Date
- 2012-12-06
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 7
- Registration Number
- NCT00623974
- Locations
- 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
Effect of Pulmonary Rehabilitation on Surgical Outcomes in the Cancer Setting
Phase 2
Active, not recruiting
- Conditions
- Lung Cancer
- Interventions
- Other: QuestionnaireBehavioral: Pulmonary Rehabilitation
- First Posted Date
- 2008-02-20
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 75
- Registration Number
- NCT00618553
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer
Phase 1
Completed
- Conditions
- Pancreatic Cancer
- Interventions
- First Posted Date
- 2008-02-13
- Last Posted Date
- 2016-08-01
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT00614653
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Female Sexual Dysfunction Intervention
Completed
- Conditions
- Sexual Dysfunction
- Interventions
- Behavioral: Focus GroupBehavioral: TENDRILSBehavioral: QuestionnairesBehavioral: Sexual Counseling Sessions
- First Posted Date
- 2008-02-13
- Last Posted Date
- 2015-01-09
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 91
- Registration Number
- NCT00614276
- Locations
- 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
Bevacizumab and Temsirolimus in Patients With Advanced Malignancy
Phase 1
Completed
- Conditions
- Advanced Cancer
- Interventions
- Drug: BevacizumabDrug: TemsirolimusProcedure: Additional Blood DrawnProcedure: BiopsyProcedure: DCE-MRI Scan
- First Posted Date
- 2008-02-08
- Last Posted Date
- 2017-12-08
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 193
- Registration Number
- NCT00610493
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Photopheresis for the Treatment of Acute Graft Versus Host Disease
Phase 2
Completed
- Conditions
- Graft Versus Host Disease
- Interventions
- Drug: MethylprednisoloneProcedure: Photopheresis
- First Posted Date
- 2008-02-07
- Last Posted Date
- 2018-06-04
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 81
- Registration Number
- NCT00609609
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Magnetic Resonance Imaging in Patients With Breast Cancer
Completed
- Conditions
- Breast Cancer
- Interventions
- Procedure: MRI
- First Posted Date
- 2008-02-07
- Last Posted Date
- 2015-07-01
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 96
- Registration Number
- NCT00610181
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath